{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T10:13:35Z","timestamp":1780049615408,"version":"3.53.1"},"reference-count":51,"publisher":"BMJ","issue":"9","license":[{"start":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T00:00:00Z","timestamp":1599609600000},"content-version":"unspecified","delay-in-days":8,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["085417ma\/Z\/08\/Z"],"award-info":[{"award-number":["085417ma\/Z\/08\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["WT091909\/B\/10\/Z"],"award-info":[{"award-number":["WT091909\/B\/10\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Glob Health"],"accepted":{"date-parts":[[2020,6,24]]},"published-print":{"date-parts":[[2020,9]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Pneumococcal conjugate vaccine (PCV) and rotavirus vaccine (RV) are key tools for reducing common causes of infant mortality. However, measurement of population-level mortality impact is lacking from sub-Saharan Africa. We evaluated mortality impact and vaccine effectiveness (VE) of PCV13 introduced in November 2011, with subsequent RV1 roll-out in October 2012, in Malawi.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We conducted two independent community-based birth cohort studies. Study 1, in northern Malawi (40000population), evaluated population impact using change-point analysis and negative-binomial regression of non-traumatic 14\u201351-week infant mortality preintroduction (1 January 2004 to 31 September 2011) and postintroduction (1 October 2011 to 1 July 2019), and against three-dose coverage. Study 2, in central Malawi (465 000 population), was recruited from 24 November 2011 to 1 June 2015. In the absence of preintroduction data, individual three-dose versus zero-dose VE was estimated using individual-level Cox survival models. In both cohorts, infants were followed with household visits to ascertain vaccination, socioeconomic and survival status. Verbal autopsies were conducted for deaths.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Study 1 included 20 291 live births and 216 infant deaths. Mortality decreased by 28.6% (95% CI: 15.3 to 39.8) post-PCV13 introduction. A change point was identified in November 2012. Study 2 registered 50 731 live births, with 454 deaths. Infant mortality decreased from 17 to 10\/1000 live births during the study period. Adjusted VE was 44.6% overall (95% CI: 23.0 to 59.1) and 48.3% (95% CI: \u22125.9 to 74.1) against combined acute respiratory infection, meningitis and sepsis-associated mortality.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>These data provide population-level evidence of infant mortality reduction following sequential PCV13 and RV1 introduction into an established immunisation programme in Malawi. These data support increasing coverage of vaccine programmes in high-burden settings.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjgh-2020-002669","type":"journal-article","created":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T03:31:43Z","timestamp":1599708703000},"page":"e002669","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":9,"title":["Population impact and effectiveness of sequential 13-valent pneumococcal conjugate and monovalent rotavirus vaccine introduction on infant mortality: prospective birth cohort studies from Malawi"],"prefix":"10.1136","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6885-6716","authenticated-orcid":false,"given":"Carina","family":"King","sequence":"first","affiliation":[{"name":"Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden"},{"name":"Institute for Global Health, University College London, London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naor","family":"Bar-Zeev","sequence":"additional","affiliation":[{"name":"International Vaccine Access Center, Department of International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA"},{"name":"Centre for Global Vaccine Research, Institute of Infection & Global Health, University of Liverpool, Liverpool, Merseyside, UK"},{"name":"Malawi-Liverpool-Wellcome Trust Clinical Research Programme, College of Medicine, University of Malawi, Blantyre, Malawi"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tambosi","family":"Phiri","sequence":"additional","affiliation":[{"name":"MaiMwana Project, Parent and Child Health Initiative, Lilongwe, Malawi"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Beard","sequence":"additional","affiliation":[{"name":"Institute for Global Health, University College London, London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hazzie","family":"Mvula","sequence":"additional","affiliation":[{"name":"Karonga Prevention Study, Malawi Epidemiology and Intervention Research Unit, Chilumba, Malawi"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia","family":"Crampin","sequence":"additional","affiliation":[{"name":"Karonga Prevention Study, Malawi Epidemiology and Intervention Research Unit, Chilumba, Malawi"},{"name":"Institute of Health & Wellbeing, University of Glasgow, Glasgow, UK"},{"name":"Department of Population Health, London School of Hygiene and Tropical Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Heinsbroek","sequence":"additional","affiliation":[{"name":"Centre for Global Vaccine Research, Institute of Infection & Global Health, University of Liverpool, Liverpool, Merseyside, UK"},{"name":"Karonga Prevention Study, Malawi Epidemiology and Intervention Research Unit, Chilumba, Malawi"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Hungerford","sequence":"additional","affiliation":[{"name":"Centre for Global Vaccine Research, Institute of Infection & Global Health, University of Liverpool, Liverpool, Merseyside, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Lewycka","sequence":"additional","affiliation":[{"name":"Nuffield Department of Medicine, Centre for Tropical Medicine, University of Oxford, Oxford, Oxfordshire, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Verani","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Whitney","sequence":"additional","affiliation":[{"name":"Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Costello","sequence":"additional","affiliation":[{"name":"Institute for Global Health, University College London, London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Mwansambo","sequence":"additional","affiliation":[{"name":"MaiMwana Project, Parent and Child Health Initiative, Lilongwe, Malawi"},{"name":"Ministry of Health, Lilongwe, Malawi"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel","family":"Cunliffe","sequence":"additional","affiliation":[{"name":"Centre for Global Vaccine Research, Institute of Infection & Global Health, University of Liverpool, Liverpool, Merseyside, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob","family":"Heyderman","sequence":"additional","affiliation":[{"name":"Malawi-Liverpool-Wellcome Trust Clinical Research Programme, College of Medicine, University of Malawi, Blantyre, Malawi"},{"name":"NIHR Global Health Research Unit on Mucosal Pathogens, Division of Infection & Immunity, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"French","sequence":"additional","affiliation":[{"name":"Centre for Global Vaccine Research, Institute of Infection & Global Health, University of Liverpool, Liverpool, Merseyside, UK"},{"name":"Malawi-Liverpool-Wellcome Trust Clinical Research Programme, College of Medicine, University of Malawi, Blantyre, Malawi"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,9,9]]},"reference":[{"key":"2025073014000974000_5.9.e002669.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61698-6"},{"key":"2025073014000974000_5.9.e002669.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61204-6"},{"key":"2025073014000974000_5.9.e002669.3","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(18)30247-X"},{"key":"2025073014000974000_5.9.e002669.4","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ1013"},{"key":"2025073014000974000_5.9.e002669.5","first-page":"72","article-title":"Impact of pneumococcal conjugate vaccines (PCV) on pneumonia, the forgotten killer of children","volume":"8","author":"Shah","year":"2016","journal-title":"Pediatr Infect Dis"},{"key":"2025073014000974000_5.9.e002669.6","first-page":"49","article-title":"Rotavirus vaccines. WHO position paper \u2013 January 2013","volume":"88","year":"2013","journal-title":"Wkly Epidemiol Rec"},{"key":"2025073014000974000_5.9.e002669.7","first-page":"129","article-title":"Pneumococcal vaccines WHO position paper--2012","volume":"87","year":"2012","journal-title":"Wkly Epidemiol Rec"},{"key":"2025073014000974000_5.9.e002669.8","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(14)70822-9"},{"key":"2025073014000974000_5.9.e002669.9","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu524"},{"key":"2025073014000974000_5.9.e002669.10","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(14)71081-3"},{"key":"2025073014000974000_5.9.e002669.11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0067324"},{"key":"2025073014000974000_5.9.e002669.12","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.vaccine.2015.01.081","article-title":"Choosing between 7-, 10- and 13-valent pneumococcal conjugate vaccines in childhood: a review of economic evaluations (2006-2014)","volume":"33","author":"Wu","year":"2015","journal-title":"Vaccine"},{"key":"2025073014000974000_5.9.e002669.13","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000000269"},{"key":"2025073014000974000_5.9.e002669.14","doi-asserted-by":"crossref","first-page":"e249","DOI":"10.1016\/S2214-109X(18)30455-8","article-title":"Effect of pneumococcal conjugate vaccine introduction on childhood pneumonia mortality in Brazil: a retrospective observational study","volume":"7","author":"Schuck-Paim","year":"2019","journal-title":"Lancet Glob Health"},{"key":"2025073014000974000_5.9.e002669.15","doi-asserted-by":"crossref","first-page":"4738","DOI":"10.1016\/j.vaccine.2016.07.027","article-title":"Impact of pneumococcal conjugate vaccine in children morbidity and mortality in Peru: time series analyses","volume":"34","author":"Suarez","year":"2016","journal-title":"Vaccine"},{"key":"2025073014000974000_5.9.e002669.16","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.jiph.2019.06.021","article-title":"Decline in childhood respiratory-related mortality after the introduction of the pneumococcal conjugate vaccine in Morocco","volume":"13","author":"Bennani Mechita","year":"2020","journal-title":"J Infect Public Health"},{"key":"2025073014000974000_5.9.e002669.17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179905","article-title":"Estimated severe pneumococcal disease cases and deaths before and after pneumococcal conjugate vaccine introduction in children younger than 5 years of age in South Africa","volume":"12","author":"von Mollendorf","year":"2017","journal-title":"PLoS One"},{"key":"2025073014000974000_5.9.e002669.18","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(14)70940-5"},{"key":"2025073014000974000_5.9.e002669.19","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(14)71060-6"},{"key":"2025073014000974000_5.9.e002669.20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0905211"},{"key":"2025073014000974000_5.9.e002669.21","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.1097\/INF.0000000000001143","article-title":"Sustained decrease in Gastroenteritis-related deaths and hospitalizations in children less than 5 years of age after the introduction of rotavirus vaccination: a time-trend analysis in Brazil (2001-2010)","volume":"35","author":"Costa","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"2025073014000974000_5.9.e002669.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.06.058"},{"key":"2025073014000974000_5.9.e002669.23","doi-asserted-by":"crossref","first-page":"e1036","DOI":"10.1016\/S2214-109X(18)30314-0","article-title":"Impact of monovalent rotavirus vaccine on diarrhoea-associated post-neonatal infant mortality in rural communities in Malawi: a population-based birth cohort study","volume":"6","author":"Bar-Zeev","year":"2018","journal-title":"Lancet Glob Health"},{"key":"2025073014000974000_5.9.e002669.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.04.053"},{"key":"2025073014000974000_5.9.e002669.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.07.006"},{"key":"2025073014000974000_5.9.e002669.26","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dys088"},{"key":"2025073014000974000_5.9.e002669.27","unstructured":"World Health Organization . Verbal autopsy standards: the 2012 WHO verbal autopsy instrument. Geneva: WHO, 2012."},{"key":"2025073014000974000_5.9.e002669.28","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1097\/EDE.0000000000000719","article-title":"Bayesian model averaging with change points to assess the impact of vaccination and public health interventions","volume":"28","author":"K\u00fcr\u00fcm","year":"2017","journal-title":"Epidemiology"},{"key":"2025073014000974000_5.9.e002669.29","unstructured":"Cox DR , Oakes D . Analysis of survival data. London: Chapman and Hall, 1984."},{"key":"2025073014000974000_5.9.e002669.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.07.062"},{"key":"2025073014000974000_5.9.e002669.31","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4067"},{"key":"2025073014000974000_5.9.e002669.32","unstructured":"Royston P , Lambert PC . Flexible parametric survival analysis using Stata: beyond the COX model. StataCorp LP, 2011."},{"key":"2025073014000974000_5.9.e002669.33","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyg082"},{"key":"2025073014000974000_5.9.e002669.34","doi-asserted-by":"crossref","DOI":"10.3402\/gha.v5i0.19281","article-title":"Strengthening standardised interpretation of verbal autopsy data: the new InterVA-4 tool","volume":"5","author":"Byass","year":"2012","journal-title":"Glob Health Action"},{"key":"2025073014000974000_5.9.e002669.35","article-title":"Comparing verbal autopsy cause of death findings as determined by physician coding and probabilistic modelling: a public health analysis of 54 000 deaths in Africa and Asia","volume":"5","author":"Byass","year":"2015","journal-title":"J Glob Health"},{"key":"2025073014000974000_5.9.e002669.36","doi-asserted-by":"crossref","first-page":"e201","DOI":"10.1016\/S2214-109X(15)00294-6","article-title":"Malawi and millennium development goal 4: a countdown to 2015 country case study","volume":"4","author":"Kanyuka","year":"2016","journal-title":"Lancet Glob Health"},{"key":"2025073014000974000_5.9.e002669.37","unstructured":"NSO . Malawi demographic and health survey 2015-16. Zomba, Malawi: NSO\/Malawi and ICF, 2017."},{"key":"2025073014000974000_5.9.e002669.38","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jpeds.2016.11.041","article-title":"Cocontribution of rotavirus and pneumococcal conjugate vaccines to the reduction of pediatric hospital visits in young children","volume":"182","author":"Ben-Shimol","year":"2017","journal-title":"J Pediatr"},{"key":"2025073014000974000_5.9.e002669.39","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0b013e328349287d"},{"key":"2025073014000974000_5.9.e002669.40","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)30721-4"},{"key":"2025073014000974000_5.9.e002669.41","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S2213-2600(16)00096-5","article-title":"Aetiology of childhood pneumonia in a well vaccinated South African birth cohort: a nested case-control study of the Drakenstein child health study","volume":"4","author":"Zar","year":"2016","journal-title":"Lancet Respir Med"},{"key":"2025073014000974000_5.9.e002669.42","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)71876-6"},{"key":"2025073014000974000_5.9.e002669.43","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1016\/S2214-109X(15)00215-6","article-title":"Mortality and its risk factors in Malawian children admitted to hospital with clinical pneumonia, 2001-12: a retrospective observational study","volume":"4","author":"Lazzerini","year":"2016","journal-title":"Lancet Glob Health"},{"key":"2025073014000974000_5.9.e002669.44","unstructured":"Symposium Secretariat . Is reduction in pneumococcal meningitis in non-vaccinated age groups in Malawi attributable to the introduction of 13-valent pneumococcal conjugate vaccine? 9th International Symposium on Pneumococci and Pneumococcal Diseases, Hyderabad, India, 2014."},{"key":"2025073014000974000_5.9.e002669.45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0168209","article-title":"Impact of the 13-Valent pneumococcal conjugate vaccine on clinical and hypoxemic childhood pneumonia over three years in central Malawi: an observational study","volume":"12","author":"McCollum","year":"2017","journal-title":"PLoS One"},{"key":"2025073014000974000_5.9.e002669.46","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000000082"},{"key":"2025073014000974000_5.9.e002669.47","doi-asserted-by":"crossref","first-page":"5242","DOI":"10.1016\/j.vaccine.2019.07.063","article-title":"Impact of vaccination delay on deaths averted by pneumococcal conjugate vaccine: modeled effects in 8 country scenarios","volume":"37","author":"Carter","year":"2019","journal-title":"Vaccine"},{"key":"2025073014000974000_5.9.e002669.48","doi-asserted-by":"crossref","first-page":"893","DOI":"10.2471\/BLT.16.173401","article-title":"Pulse oximetry for children with pneumonia treated as outpatients in rural Malawi","volume":"94","author":"McCollum","year":"2016","journal-title":"Bull World Health Organ"},{"key":"2025073014000974000_5.9.e002669.49","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.82.1.120"},{"key":"2025073014000974000_5.9.e002669.50","first-page":"669","article-title":"The accuracy of mother's reports about their children's vaccination status","volume":"67","author":"Gareaballah","year":"1989","journal-title":"Bull World Health Organ"},{"key":"2025073014000974000_5.9.e002669.51","doi-asserted-by":"publisher","DOI":"10.1016\/S0277-9536(97)10049-1"}],"container-title":["BMJ Global Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjgh-2020-002669","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T21:00:19Z","timestamp":1753909219000},"score":1,"resource":{"primary":{"URL":"https:\/\/gh.bmj.com\/lookup\/doi\/10.1136\/bmjgh-2020-002669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":51,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020,9,9]]},"published-print":{"date-parts":[[2020,9]]}},"alternative-id":["10.1136\/bmjgh-2020-002669"],"URL":"https:\/\/doi.org\/10.1136\/bmjgh-2020-002669","relation":{},"ISSN":["2059-7908"],"issn-type":[{"value":"2059-7908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9]]}}}